Acura Pharmaceuticals Inc (ACUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1993 | 12-1992 | 09-1992 | 06-1992 | 03-1992 | |
| Sales | 14,409 | 13,864 | 12,931 | 11,662 | 11,411 |
| Cost of Goods | 10,405 | N/A | 9,219 | 8,399 | 8,077 |
| Gross Profit | 4,004 | 13,864 | 3,712 | 3,263 | 3,334 |
| Operating Expenses | 2,980 | 0 | 2,770 | 2,512 | 2,371 |
| Operating Income | 1,429 | 13,864 | 1,161 | 1,150 | 1,040 |
| Interest Expense | 146 | 0 | 96 | 102 | 100 |
| Other Income | 42 | -14,968 | 27 | 24 | 10 |
| Pre-tax Income | 1,325 | -1,104 | 1,092 | 1,072 | 950 |
| Income Tax | 596 | -219 | 469 | 462 | 408 |
| Net Income Continuous | 729 | -884 | 660 | 623 | 529 |
| Net Income Discontinuous | -267 | -1,998,000 | 0 | -1,998,000 | -1,998,000 |
| Net Income | $462 | $-884 | $660 | $623 | $529 |
| EPS Basic Total Ops | 3.00 | -6.00 | 4.87 | 4.50 | 4.00 |
| EPS Basic Continuous Ops | 5.02 | -6.17 | 4.87 | 4.53 | 3.82 |
| EPS Basic Discontinuous Ops | -1.84 | -13,952.51 | N/A | -14,520.35 | -14,425.99 |
| EPS Diluted Total Ops | 3.00 | -6.00 | 4.87 | 4.50 | 4.00 |
| EPS Diluted Continuous Ops | 5.30 | -6.17 | 4.87 | 4.65 | 3.95 |
| EPS Diluted Discontinuous Ops | -1.94 | -13,952.51 | N/A | -14,910.45 | -14,932.74 |
| EBITDA(a) | $1,429 | $13,864 | $1,161 | $1,150 | $1,040 |